In recent years, there has been a significant rise in the interest and acceptance of psilocybin mushrooms across Canada.

Psychedelic therapy is set to launch in Colorado this spring, with the state considering licenses for healing centers, ...

Recent predictions for the psychedelic drugs market are loud, forecasting a $6.4 billion value in 2034, with psilocybin occupying a prominent place. Now, in terms of the legal commercialization of ...

Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.

As awareness of the potential benefits of psilocybin mushrooms grows, more Canadians are seeking safe and reliable ways to ...

One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new report suggests. A second new ...

Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression as conventional treatment, a small, early-stage study has suggested. But when it comes to ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on COMPASS Pathways (CMPS – Research Report) today and set a price target of ...